Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76fb5796d-vfjqv Total loading time: 0 Render date: 2024-04-26T15:23:18.345Z Has data issue: false hasContentIssue false

Chapter 5 - The Consultation with the Poor Responder

Published online by Cambridge University Press:  22 August 2018

By
Paul Atkinson  and
William L. Ledger
Edited by
Ying Cheong ,
Togas Tulandi  and
Tin-Chiu Li
Ying Cheong
Affiliation:
University of Southampton
Togas Tulandi
Affiliation:
McGill University, Montréal
Tin-Chiu Li
Affiliation:
The Chinese University of Hong Kong
Get access
Type
Chapter
Information
Practical Problems in Assisted Conception , pp. 14 - 18
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Oudendijk, J., Yarde, F., Eijkemans, M., Broekmans, F. and Broer, S.. The poor responder in IVF: Is the prognosis always poor? A systematic review. Hum. Reprod. Update 2012;18:1–11.CrossRefGoogle ScholarPubMed
Polyzos, N. and Devroey, P.. A systematic review of randomized trials for the treatment of poor ovarian responders: Is there any light at the end of the tunnel? Fertil. Steril. 2011;96:1058.e7–61.e7.Google Scholar
Ferraretti, A., La Marca, A., Fauser, B., Tarlatzis, B., Nargund, G. and Gianroli, L.. ESHRE consensus on the definition of the “poor response” to ovarian stimulation for in vitro fertilization: The Bologna criteria. Hum. Reprod. 2011;26:1616–24.CrossRefGoogle ScholarPubMed
La Marca, A., Sighinolfi, G., Radi, D., Argento, C., Baraldi, E., Artenisio, A., Stabile, G. and Volpe, A.. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum. Reprod. Update 2010;16:113–30.CrossRefGoogle ScholarPubMed
Galey-Fontaine, J., Cedrin-Durnerin, I., Chaibi, R., Massin, N. and Hugues, J.. Age and ovarian reserve are distinct predictive factors of cycle outcome in low responders. Repro. Biomed. Online 2005;10:94–99.Google Scholar
Rombauts, L., Lambalk, C., Schultze-Mosgau, A., van Kuijk, J., Verweij, P., Gates, D., Gordon, K. and Griesinger, G.. Intercycle variability of the ovarian response in patients undergoing repeated stimulation with corifollitropin alfa in a gonadotropin-releasing hormone antagonist protocol. Fertil. Steril. 2015;104:884–90.CrossRefGoogle Scholar
Berkkanoglu, M. and Ozgur., K. What is the optimum maximal gonadotropin dosage used in microdose flare-up cycles in poor responders? Fertil. Steril. 2010;94:662–5.Google Scholar
Verberg, M., Eijkemans, M., Heijnen, E., Broekmans, F., de Klerk, C., Fauser, B. and Macklon, N.. Why do couples drop-out from IVF treatment? A prospective cohort study. Hum. Reprod. 2008;23:2050–5.CrossRefGoogle ScholarPubMed
Nagels, H., Rishworth, J., Siristattidis, C. and Kroon, B.. Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction. Cochrane Database of Systematic Reviews 2015;11:CD009749.Google Scholar
Konig, T., van der Houwen, L., Overbeek, A., Hendriks, M., Beutler-Beemsterboer, S.,Kuchenbecker, W., Renckens, C., Bernardus, R., Schats, R., Homburg, R., Hompes, P. and Lambalk, C.. Recombinant LH supplementation to a standard GnRH antagonist protocol in women of 35 years or older undergoing IVF/ICSI: A randomized controlled multicentre study. Hum. Reprod. 2013;28:2804–12.CrossRefGoogle ScholarPubMed
Ferraretti, A., Gianaroli, L., Motrenko, T., Feliciani, E., Tabanelli, C. and Magli, M.. LH pretreatment as a novel strategy for poor responders. Biomed. Res. Inter. 2014; Article ID 926172.CrossRefGoogle ScholarPubMed
Norman, R. A randomized double blind placebo controlled study of recombinant human growth hormone (r-HGH) on live birth rates in women who are poor responders. Abstract O-082. ESHRE Helsinki 2016.Google Scholar
Nardo, L., El-Toukhy, T., Stewart, J., Balen, A. and Potdar, N.. British Fertility Society Policy and Practice Committee: Adjuvants in IVF: evidence for good clinical practice. Hum. Fertil. (Camb.) 2015;18:2–15.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×